Emergent Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2013	FY 2012	FY 2011
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011
Revenue	0.12	0.17	0.99	1.37	0.71
Revenue Growth (YoY)	-28.48%	-83.11%	-27.52%	93.19%	194.95%
Cost of Revenue	0.04	0.05	0.32	0.56	0.46
Gross Profit	0.08	0.12	0.67	0.8	0.25
Selling, General & Admin	0.26	0.18	0.48	0.58	-
Research & Development	0	0	-	-	-
Amortization of Goodwill & Intangibles	0.02	0.02	-	-	-
Operating Expenses	0.28	0.2	0.48	0.58	-
Operating Income	-0.2	-0.08	0.19	0.23	0.25
Interest Expense	-0.09	-	-	-0.02	-
Interest & Investment Income	-	-	0	0	0
Other Non Operating Income (Expenses)	-0	-0	-	-	-
Pretax Income	-0.29	-0.08	0.19	0.21	0.25
Income Tax Expense	-	-	0.07	0.08	-
Earnings From Continuing Operations	-0.29	-0.08	0.12	0.13	0.25
Minority Interest in Earnings	0	0	-	-	-
Net Income	-0.29	-0.08	0.12	0.13	0.25
Net Income to Common	-0.29	-0.08	0.12	0.13	0.25
Net Income Growth	-	-	-8.06%	-48.06%	424.81%
Shares Outstanding (Basic)	58	58	25	24	23
Shares Outstanding (Diluted)	83	80	25	25	23
Shares Change (YoY)	3.97%	222.30%	-	7.83%	4.37%
EPS (Basic)	-0.00	-0.00	0.00	0.01	0.01
EPS (Diluted)	-0.00	-0.00	0.00	0.01	0.01
EPS Growth	-	-	-7.92%	-51.90%	402.92%
Gross Margin	66.47%	72.62%	67.59%	58.74%	35.31%
Operating Margin	-166.91%	-45.45%	19.11%	16.51%	35.31%
Profit Margin	-241.51%	-47.33%	12.23%	9.64%	35.85%
EBITDA	-0.18	-0.06	0.19	0.23	-
EBITDA Margin	-150.18%	-33.48%	19.15%	16.53%	-
D&A For EBITDA	0.02	0.02	0	0	-
EBIT	-0.2	-0.08	0.19	0.23	0.25
EBIT Margin	-166.91%	-45.45%	19.11%	16.51%	35.31%
Effective Tax Rate	-	-	36.64%	37.80%	-
Revenue as Reported	-	-	0.99	1.37	0.71

Source: S&P Global Market Intelligence. Standard template. Financial Sources.